文献速递妇产影像胸部CT

宫颈癌随访患者胸部转移的频率与危险因素及横断面胸部影像检查的优化使用

Frequency and risk factors of thoracic metastases and optimisation of the use of cross-sectional chest imaging in follow-up patients with cervical cancer.
PubMed 文献 · Clin Radiol · 2019-02-13

该研究纳入2004至2015年间361例经组织病理学证实的宫颈癌患者,随访至少1年,分析胸部转移的频率及危险因素。多因素Cox回归显示腺癌/腺鳞癌、高FIGO分期及初始腹内淋巴结转移与胸部转移独立相关。作者认为评估胸部转移的不良预后因素可能有助于减少不必要的胸部横断面CT检查。

要点

  • 腺癌/腺鳞癌、高FIGO分期、初始腹内淋巴结转移是胸部转移的独立危险因素。
  • 手术治疗亚组中,中高危复发分类、高FIGO分期及其他组织学类型为独立预测因素。
  • 361例中仅31例发生胸部转移,不符合上述条件者极少。

核心结论

  • 评估胸部转移的阴性预后因素可能有助于减少胸部横断面CT检查的需求。

研究设计与样本

  • 研究于2004至2015年开展,纳入361例连续的组织病理学证实的宫颈癌患者,随访至少1年,使用电子病历及所有可用影像模式记录患者和肿瘤特征及胸部转移时间,采用单因素和多因素Cox比例风险模型评估关联。

诊断标准与关键数值

  • 多因素回归显示腺癌/腺鳞癌(HR 2.46;95%CI 1.06至5.72)、其他组织学类型(HR 5.61;95%CI 1.81至17.42)、高FIGO分期(HR 2.84;95%CI 1.09至7.37)及初始腹内淋巴结转移(HR 2.46;95%CI 1.02至5.90)与胸部转移显著独立相关。
  • 手术治疗亚组分析中,中高危复发分类(HR 5.12;95%CI 1.14至22.94)、高FIGO分期(HR 2.73;95%CI 1.05至7.13)及其他组织学类型(HR 11.51;95%CI 3.66至36.19)为胸部转移的独立预测因素。
  • 361例中31例发生胸部转移;361例中2例及313例中2例发生胸部转移但不符合上述条件者分别位于各自的评估组中。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To optimise cross-sectional chest imaging usage by identifying frequency and risk factors associated with thoracic metastases in cervical cancer patients after initial definitive treatment.

MATERIALS AND METHODS: This study, conducted during 2004-2015, examined 361 consecutive patients with histopathologically proven cervical carcinoma with at least 1 year of follow-up. Electronic medical records and all available imaging modes were used to record and assess patient and tumour characteristics and timing of thoracic metastases. Associations with these characteristics and thoracic metastases were assessed using univariate and multivariable Cox proportional hazards modelling.

RESULTS: Of the 361 patients, 31 developed thoracic metastases. Multivariate regression results showed that adeno/adenosquamous carcinomas (hazard ratio [HR], 2.46; 95% confidence interval [CI], 1.06 to 5.72), other histology (HR, 5.61; 95% CI, 1.81 to 17.42), high International Federation of Gynaecology and Obstetrics (FIGO) stage (HR, 2.84; 95% CI, 1.09 to 7.37), and presence of initial intra-abdominal lymph node metastases (HR, 2.46; 95% CI, 1.02 to 5.90) were associated significantly and independently with thoracic metastases. The second analysis among the subgroup of surgical treatment identified intermediate-high risk classification of recurrence (HR, 5.12; 95% CI, 1.14 to 22.94), high FIGO stage (HR, 2.73; 95% CI, 1.05 to 7.13), and other histology (HR, 11.51; 95% CI, 3.66 to 36.19) as independent predictors of thoracic metastases. Two of the 361 and 2/313 patients with thoracic metastases who did not correspond to the conditions above were in the respective evaluation groups.

CONCLUSION: Assessment of negative prognostic factors for thoracic metastases might contribute to reduced need for chest cross-sectional chest computed tomography examinations.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Nakao KK, Kido A, Imai T, et al. Frequency and risk factors of thoracic metastases and optimisation of the use of cross-sectional chest imaging in follow-up patients with cervical cancer. Clin Radiol. 2019. PMID: 30771995. doi:10.1016/j.crad.2018.11.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。